The Latest Cardiac and Vascular News
Mavacamten Is a Potential First-in-Class Medicine with Compelling Data in the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Mavacamten Will Be a Medium- and Long-Term Growth Driver Presenting a Significant Commercial Opportunity upon Approval Promising Portfolio of Pipeline Candidates Strengthens and Extends Bristol Myers Squibb’s Leading Cardiovascular Franchise Expected to […]
BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Technologies, LLC, a global innovator in the development, production and commercialization of diagnostic and therapeutic radiopharmaceuticals, today announced the promotion of Chief Financial Officer Paul Estrem, to Executive Vice President. Mr. Estrem has also been appointed to the NorthStar Board of Managers, effective October 12, 2020, […]
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter Ventricular Restoration (TCVR), today announced that Chris Wolff has been named Vice President of U.S. Sales. In this role, Mr. Wolff will be responsible for driving enrollment in the ongoing ALIVE Trial […]
‘Control Cholesterol’ to Support the NHS in Delivering on Long-Term Plan Ambitions and Improve Health Outcomes for Patients in the North West Coast of England Quality Management Approach Aims to Help Predict and Prevent Heart Attacks and Strokes For More Than 300,000 People With Dangerously High Cholesterol Levels CAMBRIDGE, England–(BUSINESS […]
WINNIPEG, AB, Oct. 5, 2020 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, announces that through its wholly-owned subsidiary, Medicure International Inc., it has entered into a License, Manufacture and Supply Agreement (the “Agreement”) with Reliance Life Sciences Private Limited (“RLS”) for a cardiovascular biosimilar (the […]
SUNNYVALE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that medical device industry veteran Rick Anderson has joined its board of directors. Anderson brings over 30 years of senior executive […]
Heart Failure Patients in Phase 3 Clinical Trial of Omecamtiv Mecarbil Are at High Risk of Cardiovascular Events and Symptom Burden SOUTH SAN FRANCISCO, Calif., Oct. 02, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that a manuscript detailing the baseline characteristics from GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), the Phase […]
First Report of TransAeris® Diaphragm Pacer (DP) in High Risk Cardiac Surgeries under FDA Emergency Use Authorization OBERLIN, Ohio, Oct. 1, 2020 /PRNewswire/ — Synapse Biomedical, Inc®. (www.synapsebiomedical.com) announced today that surgeons at University Hospitals Cleveland Medical Center have improved the prognosis of several cardiac patients after the use of TransAeris DP […]
DUBLIN, Oct. 1, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-antiplatelet therapy (DAPT) labeling with an expanded indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx™ DES. The Resolute Onyx DES […]
TEL AVIV, Israel, Oct. 1, 2020 /PRNewswire/ — Vascular Graft Solutions Ltd. (VGS), an Israel-based innovative commercial-stage medical device company, announced today that the China National Medical Products Administration (NMPA) granted Innovative Medical Device Designation for VEST™, an external stent for vein grafts in coronary artery bypass surgery. VEST™ was proven to mitigate […]
